Thrivent Financial For Lutherans Gilead Sciences, Inc. Transaction History

Thrivent Financial For Lutherans

$52.6 Billion
Q3 2024

A detailed history of Thrivent Financial For Lutherans transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 2,187,446 shares of GILD stock, worth $197 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

2,187,446

Previous 2,159,356 1.3%

Holding current value

$197 Million

Previous $148 Million 23.79%

% of portfolio

0.35%

Previous 0.3%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$66.59 - $83.99 $1.87 Million - $2.36 Million	28,090 Added 1.3%	2,187,446 $183 Million
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $79.7 Million - $92 Million	1,262,193 Added 140.69%	2,159,356 $148 Million
Q1 2024 May 14, 2024	SELL	$71.58 - $87.29 $39.5 Million - $48.2 Million	-551,858 Reduced 38.08%	897,163 $65.7 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $4.81 Million - $5.45 Million	-65,616 Reduced 4.33%	1,449,021 $117 Million
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $6.5 Million - $7.09 Million	-87,866 Reduced 5.48%	1,514,637 $114 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $351,014 - $400,380	4,618 Added 0.29%	1,602,503 $124 Million
Q1 2023 May 17, 2023	SELL	$77.31 - $88.08 $22 Million - $25 Million	-283,937 Reduced 15.09%	1,597,885 $133 Million
Q4 2022 Feb 08, 2023	BUY	$62.32 - $89.47 $2.29 Million - $3.29 Million	36,782 Added 1.99%	1,881,822 $162 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $55.9 Million - $63.9 Million	939,524 Added 103.76%	1,845,040 $114 Million
Q2 2022 Aug 16, 2022	SELL	$57.72 - $65.01 $9.41 Million - $10.6 Million	-163,077 Reduced 15.26%	905,516 $56 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $16.3 Million - $20.4 Million	281,300 Added 35.73%	1,068,593 $63.5 Million
Q4 2021 Feb 16, 2022	BUY	$64.88 - $73.64 $5.55 Million - $6.29 Million	85,476 Added 12.18%	787,293 $57.1 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $9.68 Million - $10.4 Million	143,040 Added 25.6%	701,817 $49 Million
Q2 2021 Sep 24, 2021	BUY	$63.47 - $69.35 $1.23 Million - $1.34 Million	19,393 Added 3.6%	558,777 $38.5 Million
Q2 2021 Aug 19, 2021	BUY	$63.47 - $69.35 $13.9 Million - $15.2 Million	219,698 Added 68.72%	539,384 $37.1 Million
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $2.88 Million - $3.28 Million	-47,979 Reduced 13.05%	319,686 $20.7 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $13.5 Million - $15.4 Million	-237,847 Reduced 39.28%	367,665 $21.4 Million
Q3 2020 Nov 10, 2020	BUY	$62.1 - $78.08 $2.05 Million - $2.57 Million	32,931 Added 5.75%	605,512 $38.3 Million
Q2 2020 Aug 12, 2020	SELL	$72.34 - $84.0 $886,309 - $1.03 Million	-12,252 Reduced 2.09%	572,581 $44.1 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $73.6 Million - $94.2 Million	-1,174,470 Reduced 66.76%	584,833 $43.7 Million
Q4 2019 Feb 13, 2020	SELL	$61.62 - $67.78 $4.47 Million - $4.91 Million	-72,482 Reduced 3.96%	1,759,303 $114 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $5.39 Million - $5.95 Million	86,228 Added 4.94%	1,831,785 $116 Million
Q2 2019 Aug 13, 2019	BUY	$61.87 - $69.38 $26.7 Million - $30 Million	431,799 Added 32.87%	1,745,557 $118 Million
Q1 2019 May 14, 2019	BUY	$62.53 - $70.05 $19.8 Million - $22.2 Million	317,232 Added 31.83%	1,313,758 $85.4 Million
Q4 2018 Feb 15, 2019	BUY	$60.54 - $79.0 $6.01 Million - $7.85 Million	99,308 Added 11.07%	996,526 $62.3 Million
Q3 2018 Nov 15, 2018	BUY	$71.28 - $78.92 $60.1 Million - $66.5 Million	842,620 Added 1543.32%	897,218 $69.3 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $5,385 - $6,281	83 Added 0.15%	54,598 $3.87 Million
Q1 2018 May 08, 2018	BUY	$72.84 - $88.8 $84,494 - $103,008	1,160 Added 2.17%	54,515 $4.11 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $84,739 - $99,472	1,191 Added 2.28%	53,355 $3.82 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $3.76 Million - $4.46 Million	52,164	52,164 $4.23 Million

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Account

Thrivent Financial For Lutherans Gilead Sciences, Inc. Transaction History